Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lactic acid is a small, chiral, alpha-hydroxy acid produced naturally in tissues (especially muscle) under anaerobic conditions, when pyruvate is reduced by lactate dehydrogenase. It exists in two enantiomeric forms (L-lactic acid and D-lactic acid). Lactic acid acts as both an energy substrate and a signaling molecule, influencing metabolic flux between glycolysis, gluconeogenesis, and fatty acid metabolism. It also plays roles in industrial fermentation, food preservation, and as a biomarker of tissue hypoxia or metabolic dysfunction. In medicine, blood lactic acid levels are used to monitor for lactic acidosis, commonly associated with sepsis, hypoperfusion, mitochondrial diseases, or intense exercise. Importantly, lactic acid itself is not a receptor, enzyme, transporter, or direct pharmacological target, but rather a key metabolic intermediate and signal.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lactic acid.